Turn Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	11.22	5.08	0.87	1.18
Cash & Short-Term Investments	11.22	5.08	0.87	1.18
Cash Growth	1185.55%	481.73%	-26.11%	-
Other Current Assets	0.24	0.12	0.23	0.02
Total Current Assets	11.45	5.2	1.1	1.2
Net Property, Plant & Equipment	0.07	0.08	0.12	0.03
Other Intangible Assets	0.92	0.92	0.82	0.77
Other Long-Term Assets	6.2	5.96	0.01	0.01
Total Assets	18.64	12.16	2.05	2.01
Accounts Payable	2.32	2.93	0.67	0.46
Current Portion of Leases	0.05	0.05	0.04	0.03
Other Current Liabilities	2.77	3.03	-	-
Total Current Liabilities	5.13	6	0.71	0.49
Long-Term Debt	5.94	-	-	-
Long-Term Leases	0.02	0.03	0.08	-
Other Long-Term Liabilities	1.44	1.44	1.44	1.44
Total Long-Term Liabilities	7.4	1.47	1.52	1.44
Total Liabilities	12.53	7.48	2.23	1.93
Common Stock	-	-	-	0
Additional Paid-in Capital	29.48	28.14	19.02	17.51
Accumulated Other Comprehensive Income	-	-1.07	-	-
Retained Earnings	-23.36	-22.39	-19.2	-17.43
Shareholders' Equity	6.12	4.69	-0.18	0.09
Total Liabilities & Equity	18.64	12.16	2.05	2.01
Total Debt	6.01	0.08	0.12	0.03
Net Cash (Debt)	5.21	5	0.75	1.16
Net Cash Growth	4.32%	564.72%	-34.98%	-
Net Cash Per Share	0.18	0.18	0.03	0.04
Book Value	6.12	4.69	-0.18	0.09
Book Value Per Share	0.22	0.17	-0.01	0.00
Tangible Book Value	5.2	3.76	-1	-0.68
Tangible Book Value Per Share	0.18	0.14	-0.04	-0.03

SEC Filings: 10-K · 10-Q